Anikó Kovács

3.8k total citations
108 papers, 2.6k citations indexed

About

Anikó Kovács is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Anikó Kovács has authored 108 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 39 papers in Cancer Research and 35 papers in Molecular Biology. Recurrent topics in Anikó Kovács's work include Breast Cancer Treatment Studies (26 papers), Breast Lesions and Carcinomas (15 papers) and Cancer Cells and Metastasis (12 papers). Anikó Kovács is often cited by papers focused on Breast Cancer Treatment Studies (26 papers), Breast Lesions and Carcinomas (15 papers) and Cancer Cells and Metastasis (12 papers). Anikó Kovács collaborates with scholars based in Sweden, Hungary and United States. Anikó Kovács's co-authors include Khalil Helou, Per Karlsson, Toshima Z. Parris, Szilárd Nemes, Elisabeth Werner Rönnerman, Shahin Hajizadeh, Zakaria Einbeigi, Emman Shubbar, Hanna Engqvist and K. Gunnarsdóttir and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Anikó Kovács

104 papers receiving 2.5k citations

Peers

Countries citing papers authored by Anikó Kovács

Since Specialization

Citations

This map shows the geographic impact of Anikó Kovács's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anikó Kovács with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anikó Kovács more than expected).

Fields of papers citing papers by Anikó Kovács

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anikó Kovács. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anikó Kovács. The network helps show where Anikó Kovács may publish in the future.

Co-authorship network of co-authors of Anikó Kovács

This figure shows the co-authorship network connecting the top 25 collaborators of Anikó Kovács. A scholar is included among the top collaborators of Anikó Kovács based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anikó Kovács. Anikó Kovács is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The prognostic value of changes in Ki67 following neoadjuvant chemotherapy in residual triple-negative breast cancer: a Swedish nationwide registry-based study 2025 ·Breast Cancer Research and Treatment ·(unknown), (unknown), (unknown), (unknown), Anikó Kovács, Toshima Z. Parris	1
2	Changes in HER2low and HER2-ultralow status in 47 advanced breast carcinoma core biopsies, matching surgical specimens, and their distant metastases assessed by conventional light microscopy, digital pathology, and artificial intelligence 2025 ·Breast Cancer Research and Treatment ·Anikó Kovács, Leif Klint, Barbro Linderholm, Toshima Z. Parris	1
3	Integration of personalised ultrasensitive ctDNA monitoring of patients with metastatic breast cancer to reduce imaging requirements 2024 ·International Journal of Cancer ·(unknown), Anders Ståhlberg, Daniel Andersson, (unknown), (unknown), (unknown), Anne Kavanagh, Anikó Kovács, Karolina Larsson, Barbro Linderholm, (unknown), Tobias Österlund, Sacha J. Howell, Maria Ekholm	2
4	Co-administration with A1M does not influence apoptotic response of 177Lu-octreotate in GOT1 neuroendocrine tumors 2023 ·Scientific Reports ·(unknown), Charlotte Andersson, (unknown), Amin Al-Awar, Emman Shubbar, Anikó Kovács, Bo Åkerström, Magnus Gram, Khalil Helou, Eva Forssell‐Aronsson	1
5	Trefoil factor family proteins as potential diagnostic markers for mucinous invasive ovarian carcinoma 2023 ·Frontiers in Oncology ·Elisabeth Werner Rönnerman, (unknown), Szilárd Nemes, Pernilla Dahm‐Kähler, Anikó Kovács, Per Karlsson, Toshima Z. Parris, Khalil Helou	3
6	Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancer 2023 ·Breast Cancer Research ·(unknown), (unknown), Toshima Z. Parris, Salmir Nasic, M. Sundquist, Per Karlsson, Riccardo A. Audisio, Roger Olofsson Bagge, Anikó Kovács	2
7	Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features 2023 ·Journal of Translational Medicine ·María C. Leiva, (unknown), Elena Garré, Anders Ståhlberg, Anikó Kovács, Khalil Helou, Göran Landberg	4
8	Low dose oral glucocorticoid therapy in lichen planus: A retrospective cohort study 2022 ·Indian Journal of Dermatology Venereology and Leprology ·(unknown), Anikó Kovács, Kende Lőrincz, Márta Medvecz, Miklós Sárdy	3
9	Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors 2021 ·Scientific Reports ·(unknown), Carola Andersson, Elisabeth Werner Rönnerman, (unknown), (unknown), (unknown), Anikó Kovács, Henrik Fagman, Fredrik Enlund, Barbro Linderholm	9
10	Real world data on adjuvant treatment of older HER2-positive breast cancer patients – A single institution experience through 8 years 2021 ·Cancer Treatment and Research Communications ·Leif Klint, Anikó Kovács, Elisabeth Werner Rönnerman, Barbro Linderholm	2
11	High‐risk human papillomavirus in patients with oral leukoplakia and oral squamous cell carcinoma—A multi‐centre study in Sweden, Brazil and Romania 2020 ·Oral Diseases ·(unknown), Jenny Öhman, (unknown), Mats Wallström, Göran Kjeller, Maria Andersson, Peter Horal, Magnus Lindh, Daniel Giglio, Anikó Kovács, Lars Sand, Jan‐Michaél Hirsch, (unknown), (unknown), Ioanina Părlătescu, Maria Dobre, Mihail Eugen Hinescu, Paulo Henrique Braz‐Silva, Șerban Țovaru, Bengt Hasséus	12
12	Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial 2020 ·Clinical Cancer Research ·(unknown), Henri Puttonen, Martin Sjöström, Erik Holmberg, S. Laura Chang, Felix Y. Feng, Corey Speers, Lori J. Pierce, Dan Lundstedt, Fredrika Killander, Emma Niméus, Anikó Kovács, Per Karlsson	17
13	Recurrence rates after surgical removal of oral leukoplakia—A prospective longitudinal multi-centre study 2019 ·PLoS ONE ·(unknown), (unknown), Erik Holmberg, John Bratel, Mats Wallström, (unknown), (unknown), Anikó Kovács, Jenny Öhman, Lars Sand, Jan‐Michaél Hirsch, Daniel Giglio, Göran Kjeller, Bengt Hasséus	35
14	Combined Testing of p16 Tumour-suppressor Protein and Human Papillomavirus in Patients With Oral Leukoplakia and Oral Squamous Cell Carcinoma 2019 ·Anticancer Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lars Sand, Jan‐Michaél Hirsch, Erik Holmberg, Daniel Giglio, Jenny Öhman, Anikó Kovács, Peter Horal, Magnus Lindh, Göran Kjeller, Bengt Hasséus	16
15	Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma 2010 ·Clinical Cancer Research ·Toshima Z. Parris, Anna Danielsson, Szilárd Nemes, Anikó Kovács, Ulla Delle, (unknown), (unknown), Per Karlsson, Khalil Helou	82
16	Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1 2010 ·Cancer Research ·Jeanette Nilsson, Khalil Helou, Anikó Kovács, Pär‐Ola Bendahl, Gunnar Bjursell, Mårten Fernö, Peter Carlsson, Marie Kannius‐Janson	58
17	Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray 2010 ·BMC Cancer ·(unknown), Anikó Kovács, Kristina Lövgren, Szilárd Nemes, Ulla Delle, Anna Danielsson, Toshima Z. Parris, Donal J. Brennan, Karin Jirström, Per Karlsson, Khalil Helou	30
18	Reproducibility of human epidermal growth factor receptor 2 analysis in primary breast cancer – A national survey performed at pathology departments in Sweden 2009 ·Acta Oncologica ·Lisa Rydén, (unknown), Pär‐Ola Bendahl, Thomas Hatschek, (unknown), Anikó Kovács, (unknown), Hans Olsson, Carina Strand, Mårten Fernö, (unknown)	23
19	HER2-testing in 538 consecutive breast cancer cases using FISH and immunohistochemistry 2009 ·Pathology - Research and Practice ·Anikó Kovács, Göran Stenman	20
20	Silymarin and Vitamin E do not Attenuate and Vitamin E Might Even Enhance the Antiarrhythmic Activity of Amiodarone in a Rat Reperfusion Arrhythmia Model 2001 ·Cardiovascular Drugs and Therapy ·(unknown), (unknown), Anikó Kovács, Gábor Szénási, András Vereckei	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact